• University of Western Ontario, London, Ontario, Canada – MD
  • University of Western Ontario London Health Sciences Centre, London, Ontario, Canada – Residency in Internal Medicine
  • University of Western Ontario London Health Sciences Centre – Fellowship in Cardiovascular Medicine
  • Georgetown University, Washington D.C. - Interventional Cardiology/Endovascular Medicine Fellowship
  • National Heart Lung and Blood Institute, NIH, Bethesda, Maryland - Intramural Post Doctorate Fellow, Interventional MRI/Cardiac and Peripheral Interventions/Regenerative Medicine

Professional Activities

Dr. Amish Raval is a faculty member in the Division of Cardiovascular Medicine within the Department of Medicine and holds an affiliate appointment with the Department of Biomedical Engineering in the College of Engineering. He is the recipient of many awards, including NIH R01 and U01 grants and the Wisconsin Alumni Research Foundation Innovation Award for “Best Inventor”.  Dr. Raval is board certified in internal medicine and cardiovascular diseases. He also holds certification of Added Qualification in Interventional Cardiology. He is a member of numerous professional societies including the Society for Cardiac Angiography and Intervention, American College of Cardiology and the American Heart Association.

Clinical Specialties

Dr. Raval specializes in interventional cardiology, working to minimize the effects of coronary artery disease and valvular heart disease. He performs heart catheterizations to correct valvular and congenital defects and cardiomyopathies, coronary angiography, coronary revascularization and related coronary and pulmonary procedures. He is the Medical Director of the UW Health STEMI program. 

Research Interests

View Dr. Amish Raval's publications at NCBI My Bibliography

In addition to being the UW Director of Clinical Cardiovascular Research, Dr. Raval’s translational research focus is development and therapeutic delivery of biologic agents, including stem cells and scaffolds for cardiac and vascular disease.  He has numerous peer-reviewed publications and patents in this field.  He is the principal investigator of numerous cardiovascular regenerative medicine clinical trials, including the Stem Cell Revascularization in Patients with Critical Limb Ischemia (SCRIPT-CLI) and the CardiAMP Phase III clinical trial.  His laboratory is funded through a combination sources including the NIH, Wisconsin Alumni Research Foundation, and Industry Sponsored Research.